-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
OrganiGram Holdings Inc. (NASDAQ:OGI) recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
CEO Beena Goldenberg attributed the revenue growth to the company's "innovative product launches, comprehensive retail distribution, sales execution, and operational excellence."
In his recent note, Cantor Fitzgerald's analyst Pablo Zuanic said that the company is sustainably gaining a share within the cannabis market.
"In the challenging context of the Canadian market, we think OGI remains one of the best operators," he said.
The Analyst
Zuanic retained an "Overweight" rating on the company's stock while keeping the price target of CA$2.90.
The Thesis
The analyst said that out of 19% sequential sales in the fourth quarter, which the company reported on Monday, 70% accounted for exports, even though adjusted gross margins dropped 1.4pt to 22.8%.
Now, the company's management expects additional sales growth in the next fiscal year.
"We believe it [company] will gain market share on the back of expanded capacity (it was capacity constrained in parts of FY22) and SKU innovation," Zuanic said, "For the Nov qtr, it guides for gross margin expansion (yields, efficiencies, and operating leverage post the expansion in the Moncton facility)."
Price Action
OrganiGram's shares traded 2.00% higher at $1.02 per share at the time of writing on Wednesday morning.
Related News
- Organigram Launches Holy Mountain Cannabis Brand Focusing On Value Whole Flower And Hash Categories
- Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
- This $85B Tobacco Giant Just Invested $37M In A German Cannabis Company Also Supported By Snoop Dogg
Photo: Courtesy of Markus Winkler on Unsplash
OrganiGram Holdings Inc. (NASDAQ:OGI) recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
OrganiGram Holdings Inc.納斯達克(Kleiner Perkins Caufield&Byers)(股票代碼:OGI)最近公佈,其2022財年的淨收入從上一財年的7,920萬加元增長至1.458億加元(合1.079億美元),主要原因是娛樂和國際收入增加,但部分被醫療銷售額的下降所抵消。
CEO Beena Goldenberg attributed the revenue growth to the company's "innovative product launches, comprehensive retail distribution, sales execution, and operational excellence."
首席執行官貝娜·戈登伯格該公司將收入增長歸功於“創新的產品發佈、全面的零售分銷、銷售執行和卓越的運營”。
In his recent note, Cantor Fitzgerald's analyst Pablo Zuanic said that the company is sustainably gaining a share within the cannabis market.
在他最近的報告中,康託·菲茨傑拉德的分析師巴勃羅·祖阿尼奇表示該公司正在可持續地獲得大麻市場的份額。
"In the challenging context of the Canadian market, we think OGI remains one of the best operators," he said.
“在加拿大市場充滿挑戰的背景下,我們認為OGI仍是最好的運營商之一,”他説。
The Analyst
《分析師》
Zuanic retained an "Overweight" rating on the company's stock while keeping the price target of CA$2.90.
Zuanic對該公司股票的評級仍為“增持”,同時維持2.90加元的目標價。
The Thesis
這篇論文是
The analyst said that out of 19% sequential sales in the fourth quarter, which the company reported on Monday, 70% accounted for exports, even though adjusted gross margins dropped 1.4pt to 22.8%.
這位分析師説,在該公司週一公佈的第四季度19%的環比銷售額中,70%來自出口,儘管調整後的毛利率下降了1.4個百分點,至22.8%。
Now, the company's management expects additional sales growth in the next fiscal year.
現在,該公司管理層預計下一財年的銷售額將進一步增長。
"We believe it [company] will gain market share on the back of expanded capacity (it was capacity constrained in parts of FY22) and SKU innovation," Zuanic said, "For the Nov qtr, it guides for gross margin expansion (yields, efficiencies, and operating leverage post the expansion in the Moncton facility)."
我們相信這一點。[公司]將在擴大產能(在22財年部分地區受到產能限制)和SKU創新的支持下獲得市場份額,祖阿尼克説,對於11月的季度,它指導毛利率擴張(蒙克頓工廠擴張後的收益率、效率和運營槓桿)。
Price Action
價格行動
OrganiGram's shares traded 2.00% higher at $1.02 per share at the time of writing on Wednesday morning.
在撰寫本文時,OrganiGram的股價週三上午上漲2.00%,至每股1.02美元。
Related News
相關新聞
- Organigram Launches Holy Mountain Cannabis Brand Focusing On Value Whole Flower And Hash Categories
- Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
- This $85B Tobacco Giant Just Invested $37M In A German Cannabis Company Also Supported By Snoop Dogg
- OrganiGram推出聖山大麻品牌,專注於價值、全花和哈希類別
- OrganiGram將向以色列大麻公司InterCure供應多達2萬公斤的乾花
- 這家價值850億美元的煙草巨頭剛剛向一家德國大麻公司投資了3700萬美元,該公司也得到了Snoop Dogg的支持
Photo: Courtesy of Markus Winkler on Unsplash
圖片:由Markus Winkler在UnSplash上提供
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧